Harnessing Genomic Instability to Produce Better Therapeutics: College of Pharmacy Research Seminar

Dr. Sherif F. El-Khamisy, Professor of Molecular Medicine and Director of the Institute of Cancer Therapeutics, Bradford University, UK and Director of Ethical Tissue Biobank, Bradford University, UK, Professor El-Khamisy’s Ph.D. was on genome stability from the University of Sussex UK, followed by a postdoctoral fellowship at St Jude Hospital in the USA.

He established his own lab at the University of Sheffield, UK in 2013 and became a fellow of the Lister Institute of Preventative Medicine.

In 2014, he established a Genome Center in Egypt as part of an initiative led by the 1999 Nobel Laureate, Ahmed Zewail. In 2018 he co-founded the Sheffield Healthy Lifespan Institute.

Dr. El-Khamisy gave a scientific research presentation titled:

Harnessing the genomic instability feature of our mammalian cells to produce a better therapeutics

The presentation elaborated on the journey of drug discovery from the point of conceptualizing new drug targets to identifying these targets and validating and finally suggesting a proper intervention.

Dean Sherief Khalifa commented: It was a pleasure to host Dr. El-Khamisy’s seminar presentation and we look forward to a strong research collaboration between GMU and Bradford University.